Literature DB >> 25340478

Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoB.

Allan D Sniderman1, Benoit Lamarche, John H Contois, Jacqueline de Graaf.   

Abstract

PURPOSE OF REVIEW: Conventional methods, comparing the concentration of cholesterol to particle number as indices of cardiovascular risk, have not produced consistent results, in large part, because they treat these variables as independent and unrelated. However, although highly correlated, apolipoprotein B particles may contain a normal mass of cholesterol or may be cholesterol-depleted or cholesterol-enriched. Discordance analysis compares the predictive power of LDL-C and non-HDL-C to apolipoprotein B and LDL particle numbers in patients in whom they differ, that is, in whom they are discordant. The advantage of discordance analysis is that the results are not diluted by concordant data in which risk predictions cannot differ. RECENT
FINDINGS: The evidence, to date, consistently demonstrates that apolipoprotein B and LDL particle numbers are more accurate indices of cardiovascular risk than LDL-C or non-HDL-C.
SUMMARY: Discordance analysis is a methodological advance that allows the clinical value of closely correlated variables to be determined and demonstrates that cardiovascular risk is more closely related to the number of atherogenic particles than to the total mass of cholesterol within them.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25340478     DOI: 10.1097/MOL.0000000000000127

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  13 in total

1.  Association between discordance of LDL-C and non-HDL-C and clinical outcomes in patients with stent implantation: from the FU-Registry.

Authors:  Michiyo Shiiba; Bo Zhang; Shin-Ichiro Miura; Amane Ike; Daisuke Nose; Takashi Kuwano; Satoshi Imaizumi; Makoto Sugihara; Atushi Iwata; Hiroaki Nishikawa; Akira Kawamura; Kazuyuki Shirai; Shin'ichiro Yasunaga; Keijiro Saku
Journal:  Heart Vessels       Date:  2017-08-16       Impact factor: 2.037

Review 2.  Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council.

Authors:  Robert A Hegele; Samuel S Gidding; Henry N Ginsberg; Ruth McPherson; Frederick J Raal; Daniel J Rader; Jennifer G Robinson; Francine K Welty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-09-16       Impact factor: 8.311

3.  Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol: The Very Large Database of Lipids Study (VLDL-2B).

Authors:  Mohamed B Elshazly; Renato Quispe; Erin D Michos; Allan D Sniderman; Peter P Toth; Maciej Banach; Krishnaji R Kulkarni; Josef Coresh; Roger S Blumenthal; Steven R Jones; Seth S Martin
Journal:  Circulation       Date:  2015-07-02       Impact factor: 29.690

4.  Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in Women.

Authors:  Patrick R Lawler; Akintunde O Akinkuolie; Paul M Ridker; Allan D Sniderman; Julie E Buring; Robert J Glynn; Daniel I Chasman; Samia Mora
Journal:  Clin Chem       Date:  2017-02-07       Impact factor: 8.327

5.  Effect of Switching From Statin Monotherapy to Ezetimibe/Simvastatin Combination Therapy Compared With Other Intensified Lipid-Lowering Strategies on Lipoprotein Subclasses in Diabetic Patients With Symptomatic Cardiovascular Disease.

Authors:  Ngoc-Anh Le; Joanne E Tomassini; Andrew M Tershakovec; David R Neff; Peter W F Wilson
Journal:  J Am Heart Assoc       Date:  2015-10-20       Impact factor: 5.501

6.  Discordant Lipid Pattern and Carotid Atherosclerotic Plaque. Importance of Remnant Cholesterol.

Authors:  Walter Masson; Martín Lobo; Graciela Molinero; Daniel Siniawski
Journal:  Arq Bras Cardiol       Date:  2017-06       Impact factor: 2.000

7.  Apolipoprotein B discordance with low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in relation to coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Jing Cao; Sarah O Nomura; Brian T Steffen; Weihua Guan; Alan T Remaley; Amy B Karger; Pamela Ouyang; Erin D Michos; Michael Y Tsai
Journal:  J Clin Lipidol       Date:  2019-11-29       Impact factor: 4.766

8.  Childhood overeating is associated with adverse cardiometabolic and inflammatory profiles in adolescence.

Authors:  Christopher Hübel; Moritz Herle; Diana L Santos Ferreira; Mohamed Abdulkadir; Rachel Bryant-Waugh; Ruth J F Loos; Cynthia M Bulik; Deborah A Lawlor; Nadia Micali
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.996

9.  Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trial.

Authors:  Natia Peradze; Olivia M Farr; Nikolaos Perakakis; Iolanda Lázaro; Aleix Sala-Vila; Christos S Mantzoros
Journal:  Cardiovasc Diabetol       Date:  2019-10-31       Impact factor: 9.951

10.  Discordance Between Apolipoprotein B and LDL-Cholesterol in Young Adults Predicts Coronary Artery Calcification: The CARDIA Study.

Authors:  John T Wilkins; Ron C Li; Allan Sniderman; Cheeling Chan; Donald M Lloyd-Jones
Journal:  J Am Coll Cardiol       Date:  2016-01-19       Impact factor: 27.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.